Search Results - Giovanni Musso

Refine Results
  1. 1
    Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders

    Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders by Giovanni Musso, Roberto Gambino, Maurizio Cassader

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

    Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis by Giovanni Musso, Roberto Gambino, Maurizio Cassader

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Non‐alcoholic fatty liver disease from pathogenesis to management: an update

    Non‐alcoholic fatty liver disease from pathogenesis to management: an update by Giovanni Musso, Roberto Gambino, Maurizio Cassader

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Obesity, Diabetes, and Gut Microbiota

    Obesity, Diabetes, and Gut Microbiota by Giovanni Musso, Roberto Gambino, Maurizio Cassader

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease

    Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease by Giovanni Musso, Roberto Gambino, Maurizio Cassader

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease

    PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease by Giovanni Musso, Maurizio Cassader, Roberto Gambino

    Published 2014
    Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD

    A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD by Yusuf Yılmaz, Christopher D. Byrne, Giovanni Musso

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

    A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease by Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

    Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of ran... by Giovanni Musso, Maurizio Cassader, F. Rosina, Roberto Gambino

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials

    A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials by Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis

    Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis by Giovanni Musso, Maurizio Cassader, Elena Paschetta, Roberto Gambino

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis

    Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis by Giovanni Musso, Maurizio Cassader, Elena Paschetta, Roberto Gambino

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials

    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials by Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Diabetic ketoacidosis with SGLT2 inhibitors

    Diabetic ketoacidosis with SGLT2 inhibitors by Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver

    Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver by Giovanni Musso, Elena Paschetta, Roberto Gambino, Maurizio Cassader, Federica Molinaro

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH?

    Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH? by Roberto Gambino, Maurizio Cassader, Gianfranco Pagano, Marilena Durazzo, Giovanni Musso

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution

    Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution by Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta, Antonio Sircana

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma

    Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma by Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

    Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression by Giovanni Musso, Antonio Sircana, Francesca Saba, Maurizio Cassader, Roberto Gambino

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver

    Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dys... by Giovanni Musso, Roberto Gambino, Giovanni Pacini, Franco De Michieli, Maurizio Cassader

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: